Daré Bioscience, Inc. (DARE)
NASDAQ: DARE · Real-Time Price · USD
1.530
0.00 (0.00%)
At close: Mar 9, 2026, 4:00 PM EDT
1.550
+0.020 (1.31%)
After-hours: Mar 9, 2026, 4:20 PM EDT

Daré Bioscience Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
2227307015355
Upgrade
Market Cap Growth
-19.72%-10.87%-56.74%-54.05%178.42%240.92%
Upgrade
Enterprise Value
217173110850
Upgrade
Last Close Price
1.533.123.719.9624.0016.08
Upgrade
PS Ratio
-382.692774.4510.857.04--
Upgrade
PB Ratio
7.46-4.51-6.036.343.95-47.78
Upgrade
P/TBV Ratio
7.65--6.343.95-
Upgrade
P/FCF Ratio
-5.63----
Upgrade
P/OCF Ratio
-5.03----
Upgrade
EV/Sales Ratio
-1769.855.973.06--
Upgrade
EV/FCF Ratio
-3.59----
Upgrade
Debt / Equity Ratio
1.03-0.22-0.280.040.01-0.66
Upgrade
Debt / FCF Ratio
-0.27----
Upgrade
Net Debt / Equity Ratio
-7.052.391.80-3.08-1.333.40
Upgrade
Net Debt / EBITDA Ratio
1.230.620.301.091.320.14
Upgrade
Net Debt / FCF Ratio
2.94-2.990.231.881.790.16
Upgrade
Asset Turnover
-00.090.20--
Upgrade
Quick Ratio
1.110.740.561.153.290.67
Upgrade
Current Ratio
1.180.850.861.363.450.91
Upgrade
Return on Equity (ROE)
-2543.13%--994.69%-124.12%-205.82%-
Upgrade
Return on Assets (ROA)
-44.74%-67.57%-59.02%-39.38%-77.08%-228.45%
Upgrade
Return on Capital Employed (ROCE)
-183.30%-4765.40%-3834.00%-257.20%-98.30%24936.30%
Upgrade
Earnings Yield
-79.88%-14.93%-99.03%-43.96%-25.26%-49.80%
Upgrade
FCF Yield
-31.31%17.76%-129.65%-25.78%-18.79%-45.89%
Upgrade
Buyback Yield / Dilution
-15.58%-16.80%-3.23%-38.29%-103.23%-93.16%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.